Skip to main content
. 2003 May;56(5):368–373. doi: 10.1136/jcp.56.5.368

Figure 1.

Figure 1

Tumour cell nuclei showing immunoreactivity to (A) cyclin A and (B) HsMCM2. (C) Double staining for cyclin A and HsMCM2 is seen in tumour cells (arrows). Immunoreactivity was detected only in the tumour cell nuclei.